img

Global Crysvita Injection Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Crysvita Injection Market Insights, Forecast to 2034

X-linked hypophosphatemia, or XLH, is a hereditary skeletal disease triggered by excess production of the hormone fibroblast growth factor 23. FGF23 causes phosphate urinary excretion and hinders patients' ability to produce vitamin D. CRYSVITA is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 6 months of age and older.
The global Crysvita Injection market is projected to grow from US$ million in 2024 to US$ million by 2034, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Crysvita Injection is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Crysvita Injection is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Crysvita Injection is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The global key manufacturers of Crysvita Injection include Kyowa Kirin and Ultragenyx Pharmaceutical etc. In 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes


This report presents an overview of global market for Crysvita Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2034.
This report researches the key producers of Crysvita Injection, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Crysvita Injection, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Crysvita Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2024. Identification of the major stakeholders in the global Crysvita Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2034. Evaluation and forecast the market size for Crysvita Injection sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Kyowa Kirin and Ultragenyx Pharmaceutical etc.



By Company


Kyowa Kirin
Ultragenyx Pharmaceutical
Segment by Type
10 mg/mL
20 mg/mL
30 mg/mL

Segment by Application


Children
Adults

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Crysvita Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3Detailed analysis of Crysvita Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8China by type, by application sales and revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Crysvita Injection sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Study Coverage
1.1 Crysvita Injection Product Introduction
1.2 Market by Type
1.2.1 Global Crysvita Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 10 mg/mL
1.2.3 20 mg/mL
1.2.4 30 mg/mL
1.3 Market by Application
1.3.1 Global Crysvita Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Children
1.3.3 Adults
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Crysvita Injection Sales Estimates and Forecasts 2018-2034
2.2 Global Crysvita Injection Revenue by Region
2.2.1 Global Crysvita Injection Revenue by Region: 2018 VS 2022 VS 2034
2.2.2 Global Crysvita Injection Revenue by Region (2018-2024)
2.2.3 Global Crysvita Injection Revenue by Region (2024-2034)
2.2.4 Global Crysvita Injection Revenue Market Share by Region (2018-2034)
2.3 Global Crysvita Injection Sales Estimates and Forecasts 2018-2034
2.4 Global Crysvita Injection Sales by Region
2.4.1 Global Crysvita Injection Sales by Region: 2018 VS 2022 VS 2034
2.4.2 Global Crysvita Injection Sales by Region (2018-2024)
2.4.3 Global Crysvita Injection Sales by Region (2024-2034)
2.4.4 Global Crysvita Injection Sales Market Share by Region (2018-2034)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Crysvita Injection Sales by Manufacturers
3.1.1 Global Crysvita Injection Sales by Manufacturers (2018-2024)
3.1.2 Global Crysvita Injection Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Crysvita Injection in 2022
3.2 Global Crysvita Injection Revenue by Manufacturers
3.2.1 Global Crysvita Injection Revenue by Manufacturers (2018-2024)
3.2.2 Global Crysvita Injection Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Crysvita Injection Revenue in 2022
3.3 Global Key Players of Crysvita Injection, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Crysvita Injection Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Crysvita Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Crysvita Injection, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Crysvita Injection, Product Offered and Application
3.8 Global Key Manufacturers of Crysvita Injection, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Crysvita Injection Sales by Type
4.1.1 Global Crysvita Injection Historical Sales by Type (2018-2024)
4.1.2 Global Crysvita Injection Forecasted Sales by Type (2024-2034)
4.1.3 Global Crysvita Injection Sales Market Share by Type (2018-2034)
4.2 Global Crysvita Injection Revenue by Type
4.2.1 Global Crysvita Injection Historical Revenue by Type (2018-2024)
4.2.2 Global Crysvita Injection Forecasted Revenue by Type (2024-2034)
4.2.3 Global Crysvita Injection Revenue Market Share by Type (2018-2034)
4.3 Global Crysvita Injection Price by Type
4.3.1 Global Crysvita Injection Price by Type (2018-2024)
4.3.2 Global Crysvita Injection Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Crysvita Injection Sales by Application
5.1.1 Global Crysvita Injection Historical Sales by Application (2018-2024)
5.1.2 Global Crysvita Injection Forecasted Sales by Application (2024-2034)
5.1.3 Global Crysvita Injection Sales Market Share by Application (2018-2034)
5.2 Global Crysvita Injection Revenue by Application
5.2.1 Global Crysvita Injection Historical Revenue by Application (2018-2024)
5.2.2 Global Crysvita Injection Forecasted Revenue by Application (2024-2034)
5.2.3 Global Crysvita Injection Revenue Market Share by Application (2018-2034)
5.3 Global Crysvita Injection Price by Application
5.3.1 Global Crysvita Injection Price by Application (2018-2024)
5.3.2 Global Crysvita Injection Price Forecast by Application (2024-2034)
6 US & Canada
6.1 US & Canada Crysvita Injection Market Size by Type
6.1.1 US & Canada Crysvita Injection Sales by Type (2018-2034)
6.1.2 US & Canada Crysvita Injection Revenue by Type (2018-2034)
6.2 US & Canada Crysvita Injection Market Size by Application
6.2.1 US & Canada Crysvita Injection Sales by Application (2018-2034)
6.2.2 US & Canada Crysvita Injection Revenue by Application (2018-2034)
6.3 US & Canada Crysvita Injection Market Size by Country
6.3.1 US & Canada Crysvita Injection Revenue by Country: 2018 VS 2022 VS 2034
6.3.2 US & Canada Crysvita Injection Sales by Country (2018-2034)
6.3.3 US & Canada Crysvita Injection Revenue by Country (2018-2034)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Crysvita Injection Market Size by Type
7.1.1 Europe Crysvita Injection Sales by Type (2018-2034)
7.1.2 Europe Crysvita Injection Revenue by Type (2018-2034)
7.2 Europe Crysvita Injection Market Size by Application
7.2.1 Europe Crysvita Injection Sales by Application (2018-2034)
7.2.2 Europe Crysvita Injection Revenue by Application (2018-2034)
7.3 Europe Crysvita Injection Market Size by Country
7.3.1 Europe Crysvita Injection Revenue by Country: 2018 VS 2022 VS 2034
7.3.2 Europe Crysvita Injection Sales by Country (2018-2034)
7.3.3 Europe Crysvita Injection Revenue by Country (2018-2034)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Crysvita Injection Market Size
8.1.1 China Crysvita Injection Sales (2018-2034)
8.1.2 China Crysvita Injection Revenue (2018-2034)
8.2 China Crysvita Injection Market Size by Application
8.2.1 China Crysvita Injection Sales by Application (2018-2034)
8.2.2 China Crysvita Injection Revenue by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Crysvita Injection Market Size by Type
9.1.1 Asia Crysvita Injection Sales by Type (2018-2034)
9.1.2 Asia Crysvita Injection Revenue by Type (2018-2034)
9.2 Asia Crysvita Injection Market Size by Application
9.2.1 Asia Crysvita Injection Sales by Application (2018-2034)
9.2.2 Asia Crysvita Injection Revenue by Application (2018-2034)
9.3 Asia Crysvita Injection Sales by Region
9.3.1 Asia Crysvita Injection Revenue by Region: 2018 VS 2022 VS 2034
9.3.2 Asia Crysvita Injection Revenue by Region (2018-2034)
9.3.3 Asia Crysvita Injection Sales by Region (2018-2034)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Crysvita Injection Market Size by Type
10.1.1 Middle East, Africa and Latin America Crysvita Injection Sales by Type (2018-2034)
10.1.2 Middle East, Africa and Latin America Crysvita Injection Revenue by Type (2018-2034)
10.2 Middle East, Africa and Latin America Crysvita Injection Market Size by Application
10.2.1 Middle East, Africa and Latin America Crysvita Injection Sales by Application (2018-2034)
10.2.2 Middle East, Africa and Latin America Crysvita Injection Revenue by Application (2018-2034)
10.3 Middle East, Africa and Latin America Crysvita Injection Sales by Country
10.3.1 Middle East, Africa and Latin America Crysvita Injection Revenue by Country: 2018 VS 2022 VS 2034
10.3.2 Middle East, Africa and Latin America Crysvita Injection Revenue by Country (2018-2034)
10.3.3 Middle East, Africa and Latin America Crysvita Injection Sales by Country (2018-2034)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Kyowa Kirin
11.1.1 Kyowa Kirin Company Information
11.1.2 Kyowa Kirin Overview
11.1.3 Kyowa Kirin Crysvita Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Kyowa Kirin Crysvita Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Kyowa Kirin Recent Developments
11.2 Ultragenyx Pharmaceutical
11.2.1 Ultragenyx Pharmaceutical Company Information
11.2.2 Ultragenyx Pharmaceutical Overview
11.2.3 Ultragenyx Pharmaceutical Crysvita Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Ultragenyx Pharmaceutical Crysvita Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Ultragenyx Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Crysvita Injection Industry Chain Analysis
12.2 Crysvita Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Crysvita Injection Production Mode & Process
12.4 Crysvita Injection Sales and Marketing
12.4.1 Crysvita Injection Sales Channels
12.4.2 Crysvita Injection Distributors
12.5 Crysvita Injection Customers
13 Market Dynamics
13.1 Crysvita Injection Industry Trends
13.2 Crysvita Injection Market Drivers
13.3 Crysvita Injection Market Challenges
13.4 Crysvita Injection Market Restraints
14 Key Findings in The Global Crysvita Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Crysvita Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of 10 mg/mL
Table 3. Major Manufacturers of 20 mg/mL
Table 4. Major Manufacturers of 30 mg/mL
Table 5. Global Crysvita Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Crysvita Injection Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Crysvita Injection Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Crysvita Injection Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Crysvita Injection Revenue Market Share by Region (2018-2024)
Table 10. Global Crysvita Injection Revenue Market Share by Region (2024-2034)
Table 11. Global Crysvita Injection Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 12. Global Crysvita Injection Sales by Region (2018-2024) & (K Units)
Table 13. Global Crysvita Injection Sales by Region (2024-2034) & (K Units)
Table 14. Global Crysvita Injection Sales Market Share by Region (2018-2024)
Table 15. Global Crysvita Injection Sales Market Share by Region (2024-2034)
Table 16. Global Crysvita Injection Sales by Manufacturers (2018-2024) & (K Units)
Table 17. Global Crysvita Injection Sales Share by Manufacturers (2018-2024)
Table 18. Global Crysvita Injection Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Crysvita Injection Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Crysvita Injection, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Crysvita Injection Price by Manufacturers 2018-2024 (US$/Unit)
Table 22. Global Crysvita Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Crysvita Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crysvita Injection as of 2022)
Table 24. Global Key Manufacturers of Crysvita Injection, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Crysvita Injection, Product Offered and Application
Table 26. Global Key Manufacturers of Crysvita Injection, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Crysvita Injection Sales by Type (2018-2024) & (K Units)
Table 29. Global Crysvita Injection Sales by Type (2024-2034) & (K Units)
Table 30. Global Crysvita Injection Sales Share by Type (2018-2024)
Table 31. Global Crysvita Injection Sales Share by Type (2024-2034)
Table 32. Global Crysvita Injection Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Crysvita Injection Revenue by Type (2024-2034) & (US$ Million)
Table 34. Global Crysvita Injection Revenue Share by Type (2018-2024)
Table 35. Global Crysvita Injection Revenue Share by Type (2024-2034)
Table 36. Crysvita Injection Price by Type (2018-2024) & (US$/Unit)
Table 37. Global Crysvita Injection Price Forecast by Type (2024-2034) & (US$/Unit)
Table 38. Global Crysvita Injection Sales by Application (2018-2024) & (K Units)
Table 39. Global Crysvita Injection Sales by Application (2024-2034) & (K Units)
Table 40. Global Crysvita Injection Sales Share by Application (2018-2024)
Table 41. Global Crysvita Injection Sales Share by Application (2024-2034)
Table 42. Global Crysvita Injection Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Crysvita Injection Revenue by Application (2024-2034) & (US$ Million)
Table 44. Global Crysvita Injection Revenue Share by Application (2018-2024)
Table 45. Global Crysvita Injection Revenue Share by Application (2024-2034)
Table 46. Crysvita Injection Price by Application (2018-2024) & (US$/Unit)
Table 47. Global Crysvita Injection Price Forecast by Application (2024-2034) & (US$/Unit)
Table 48. US & Canada Crysvita Injection Sales by Type (2018-2024) & (K Units)
Table 49. US & Canada Crysvita Injection Sales by Type (2024-2034) & (K Units)
Table 50. US & Canada Crysvita Injection Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Crysvita Injection Revenue by Type (2024-2034) & (US$ Million)
Table 52. US & Canada Crysvita Injection Sales by Application (2018-2024) & (K Units)
Table 53. US & Canada Crysvita Injection Sales by Application (2024-2034) & (K Units)
Table 54. US & Canada Crysvita Injection Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Crysvita Injection Revenue by Application (2024-2034) & (US$ Million)
Table 56. US & Canada Crysvita Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 57. US & Canada Crysvita Injection Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Crysvita Injection Revenue by Country (2024-2034) & (US$ Million)
Table 59. US & Canada Crysvita Injection Sales by Country (2018-2024) & (K Units)
Table 60. US & Canada Crysvita Injection Sales by Country (2024-2034) & (K Units)
Table 61. Europe Crysvita Injection Sales by Type (2018-2024) & (K Units)
Table 62. Europe Crysvita Injection Sales by Type (2024-2034) & (K Units)
Table 63. Europe Crysvita Injection Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Crysvita Injection Revenue by Type (2024-2034) & (US$ Million)
Table 65. Europe Crysvita Injection Sales by Application (2018-2024) & (K Units)
Table 66. Europe Crysvita Injection Sales by Application (2024-2034) & (K Units)
Table 67. Europe Crysvita Injection Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Crysvita Injection Revenue by Application (2024-2034) & (US$ Million)
Table 69. Europe Crysvita Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 70. Europe Crysvita Injection Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Crysvita Injection Revenue by Country (2024-2034) & (US$ Million)
Table 72. Europe Crysvita Injection Sales by Country (2018-2024) & (K Units)
Table 73. Europe Crysvita Injection Sales by Country (2024-2034) & (K Units)
Table 74. China Crysvita Injection Sales by Type (2018-2024) & (K Units)
Table 75. China Crysvita Injection Sales by Type (2024-2034) & (K Units)
Table 76. China Crysvita Injection Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Crysvita Injection Revenue by Type (2024-2034) & (US$ Million)
Table 78. China Crysvita Injection Sales by Application (2018-2024) & (K Units)
Table 79. China Crysvita Injection Sales by Application (2024-2034) & (K Units)
Table 80. China Crysvita Injection Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Crysvita Injection Revenue by Application (2024-2034) & (US$ Million)
Table 82. Asia Crysvita Injection Sales by Type (2018-2024) & (K Units)
Table 83. Asia Crysvita Injection Sales by Type (2024-2034) & (K Units)
Table 84. Asia Crysvita Injection Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Crysvita Injection Revenue by Type (2024-2034) & (US$ Million)
Table 86. Asia Crysvita Injection Sales by Application (2018-2024) & (K Units)
Table 87. Asia Crysvita Injection Sales by Application (2024-2034) & (K Units)
Table 88. Asia Crysvita Injection Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Crysvita Injection Revenue by Application (2024-2034) & (US$ Million)
Table 90. Asia Crysvita Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 91. Asia Crysvita Injection Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Crysvita Injection Revenue by Region (2024-2034) & (US$ Million)
Table 93. Asia Crysvita Injection Sales by Region (2018-2024) & (K Units)
Table 94. Asia Crysvita Injection Sales by Region (2024-2034) & (K Units)
Table 95. Middle East, Africa and Latin America Crysvita Injection Sales by Type (2018-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Crysvita Injection Sales by Type (2024-2034) & (K Units)
Table 97. Middle East, Africa and Latin America Crysvita Injection Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Crysvita Injection Revenue by Type (2024-2034) & (US$ Million)
Table 99. Middle East, Africa and Latin America Crysvita Injection Sales by Application (2018-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Crysvita Injection Sales by Application (2024-2034) & (K Units)
Table 101. Middle East, Africa and Latin America Crysvita Injection Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Crysvita Injection Revenue by Application (2024-2034) & (US$ Million)
Table 103. Middle East, Africa and Latin America Crysvita Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 104. Middle East, Africa and Latin America Crysvita Injection Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Crysvita Injection Revenue by Country (2024-2034) & (US$ Million)
Table 106. Middle East, Africa and Latin America Crysvita Injection Sales by Country (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Crysvita Injection Sales by Country (2024-2034) & (K Units)
Table 108. Kyowa Kirin Company Information
Table 109. Kyowa Kirin Description and Major Businesses
Table 110. Kyowa Kirin Crysvita Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Kyowa Kirin Crysvita Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Kyowa Kirin Recent Developments
Table 113. Ultragenyx Pharmaceutical Company Information
Table 114. Ultragenyx Pharmaceutical Description and Major Businesses
Table 115. Ultragenyx Pharmaceutical Crysvita Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. Ultragenyx Pharmaceutical Crysvita Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Ultragenyx Pharmaceutical Recent Developments
Table 118. Key Raw Materials Lists
Table 119. Raw Materials Key Suppliers Lists
Table 120. Crysvita Injection Distributors List
Table 121. Crysvita Injection Customers List
Table 122. Crysvita Injection Market Trends
Table 123. Crysvita Injection Market Drivers
Table 124. Crysvita Injection Market Challenges
Table 125. Crysvita Injection Market Restraints
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Crysvita Injection Product Picture
Figure 2. Global Crysvita Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Crysvita Injection Market Share by Type in 2022 & 2034
Figure 4. 10 mg/mL Product Picture
Figure 5. 20 mg/mL Product Picture
Figure 6. 30 mg/mL Product Picture
Figure 7. Global Crysvita Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 8. Global Crysvita Injection Market Share by Application in 2022 & 2034
Figure 9. Children
Figure 10. Adults
Figure 11. Crysvita Injection Report Years Considered
Figure 12. Global Crysvita Injection Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 13. Global Crysvita Injection Revenue 2018-2034 (US$ Million)
Figure 14. Global Crysvita Injection Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 15. Global Crysvita Injection Revenue Market Share by Region (2018-2034)
Figure 16. Global Crysvita Injection Sales 2018-2034 ((K Units)
Figure 17. Global Crysvita Injection Sales Market Share by Region (2018-2034)
Figure 18. US & Canada Crysvita Injection Sales YoY (2018-2034) & (K Units)
Figure 19. US & Canada Crysvita Injection Revenue YoY (2018-2034) & (US$ Million)
Figure 20. Europe Crysvita Injection Sales YoY (2018-2034) & (K Units)
Figure 21. Europe Crysvita Injection Revenue YoY (2018-2034) & (US$ Million)
Figure 22. China Crysvita Injection Sales YoY (2018-2034) & (K Units)
Figure 23. China Crysvita Injection Revenue YoY (2018-2034) & (US$ Million)
Figure 24. Asia (excluding China) Crysvita Injection Sales YoY (2018-2034) & (K Units)
Figure 25. Asia (excluding China) Crysvita Injection Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Crysvita Injection Sales YoY (2018-2034) & (K Units)
Figure 27. Middle East, Africa and Latin America Crysvita Injection Revenue YoY (2018-2034) & (US$ Million)
Figure 28. The Crysvita Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Crysvita Injection in the World: Market Share by Crysvita Injection Revenue in 2022
Figure 30. Global Crysvita Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Crysvita Injection Sales Market Share by Type (2018-2034)
Figure 32. Global Crysvita Injection Revenue Market Share by Type (2018-2034)
Figure 33. Global Crysvita Injection Sales Market Share by Application (2018-2034)
Figure 34. Global Crysvita Injection Revenue Market Share by Application (2018-2034)
Figure 35. US & Canada Crysvita Injection Sales Market Share by Type (2018-2034)
Figure 36. US & Canada Crysvita Injection Revenue Market Share by Type (2018-2034)
Figure 37. US & Canada Crysvita Injection Sales Market Share by Application (2018-2034)
Figure 38. US & Canada Crysvita Injection Revenue Market Share by Application (2018-2034)
Figure 39. US & Canada Crysvita Injection Revenue Share by Country (2018-2034)
Figure 40. US & Canada Crysvita Injection Sales Share by Country (2018-2034)
Figure 41. U.S. Crysvita Injection Revenue (2018-2034) & (US$ Million)
Figure 42. Canada Crysvita Injection Revenue (2018-2034) & (US$ Million)
Figure 43. Europe Crysvita Injection Sales Market Share by Type (2018-2034)
Figure 44. Europe Crysvita Injection Revenue Market Share by Type (2018-2034)
Figure 45. Europe Crysvita Injection Sales Market Share by Application (2018-2034)
Figure 46. Europe Crysvita Injection Revenue Market Share by Application (2018-2034)
Figure 47. Europe Crysvita Injection Revenue Share by Country (2018-2034)
Figure 48. Europe Crysvita Injection Sales Share by Country (2018-2034)
Figure 49. Germany Crysvita Injection Revenue (2018-2034) & (US$ Million)
Figure 50. France Crysvita Injection Revenue (2018-2034) & (US$ Million)
Figure 51. U.K. Crysvita Injection Revenue (2018-2034) & (US$ Million)
Figure 52. Italy Crysvita Injection Revenue (2018-2034) & (US$ Million)
Figure 53. Russia Crysvita Injection Revenue (2018-2034) & (US$ Million)
Figure 54. China Crysvita Injection Sales Market Share by Type (2018-2034)
Figure 55. China Crysvita Injection Revenue Market Share by Type (2018-2034)
Figure 56. China Crysvita Injection Sales Market Share by Application (2018-2034)
Figure 57. China Crysvita Injection Revenue Market Share by Application (2018-2034)
Figure 58. Asia Crysvita Injection Sales Market Share by Type (2018-2034)
Figure 59. Asia Crysvita Injection Revenue Market Share by Type (2018-2034)
Figure 60. Asia Crysvita Injection Sales Market Share by Application (2018-2034)
Figure 61. Asia Crysvita Injection Revenue Market Share by Application (2018-2034)
Figure 62. Asia Crysvita Injection Revenue Share by Region (2018-2034)
Figure 63. Asia Crysvita Injection Sales Share by Region (2018-2034)
Figure 64. Japan Crysvita Injection Revenue (2018-2034) & (US$ Million)
Figure 65. South Korea Crysvita Injection Revenue (2018-2034) & (US$ Million)
Figure 66. China Taiwan Crysvita Injection Revenue (2018-2034) & (US$ Million)
Figure 67. Southeast Asia Crysvita Injection Revenue (2018-2034) & (US$ Million)
Figure 68. India Crysvita Injection Revenue (2018-2034) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Crysvita Injection Sales Market Share by Type (2018-2034)
Figure 70. Middle East, Africa and Latin America Crysvita Injection Revenue Market Share by Type (2018-2034)
Figure 71. Middle East, Africa and Latin America Crysvita Injection Sales Market Share by Application (2018-2034)
Figure 72. Middle East, Africa and Latin America Crysvita Injection Revenue Market Share by Application (2018-2034)
Figure 73. Middle East, Africa and Latin America Crysvita Injection Revenue Share by Country (2018-2034)
Figure 74. Middle East, Africa and Latin America Crysvita Injection Sales Share by Country (2018-2034)
Figure 75. Brazil Crysvita Injection Revenue (2018-2034) & (US$ Million)
Figure 76. Mexico Crysvita Injection Revenue (2018-2034) & (US$ Million)
Figure 77. Turkey Crysvita Injection Revenue (2018-2034) & (US$ Million)
Figure 78. Israel Crysvita Injection Revenue (2018-2034) & (US$ Million)
Figure 79. GCC Countries Crysvita Injection Revenue (2018-2034) & (US$ Million)
Figure 80. Crysvita Injection Value Chain
Figure 81. Crysvita Injection Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed